NCT00482729View on ClinicalTrials.gov

MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,246

Participants

Timeline

Start Date

June 19, 2007

Primary Completion Date

November 3, 2008

Study Completion Date

April 27, 2009

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

sitagliptin phosphate (+) metformin hydrochloride

sitagliptin/Metformin HCl 50/500 mg tablet bid, titrating up to sitagliptin/Metformin HCl 50/1000 mg tablet over 4 weeks; for a 44-wk treatment period.

DRUG

metformin

metformin 500 mg tablet bid, titrating up to 1000 mg tablets bid for a 44-wk treatment period

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00482729 - MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED) | Biotech Hunter | Biotech Hunter